(CNN) – Drugmaker Sandoz is recalling a heartburn medication in the US due to contamination with NDMA, a probable carcinogen.
The medication is Ranitidine Hydrochloride.
Sandoz said it hasn’t gotten any reports of adverse events related to product contamination.
Its parent company, Novartis, said last week that it was stopping the distribution of all the medicine.
Novartis called the measure ‘precautionary.’
Another company makes Ranitidine medication sold under the brand name Zantac but that is not being recalled.
(This story was originally published on September 25, 2019)